References
  1. Varghese, G. M., & Sobel, J. D. (2008). Fungal endocarditis. In Current Infectious Disease Reports (Vol. 10, Issue 4, pp. 275–279). Springer Science and Business Media LLC.https://doi.org/10.1007/s11908-008-0045-4
  2. Murdoch, D. R. (2009). Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century. In Archives of Internal Medicine (Vol. 169, Issue 5, p. 463). American Medical Association (AMA).https://doi.org/10.1001/archinternmed.2008.603
  3. Boland, J. M., Chung, H. H., Robberts, F. J. L., Wilson, W. R., Steckelberg, J. M., Baddour, L. M., & Miller, D. V. (2010). Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis. In Mycoses (Vol. 54, Issue 4, pp. 354–360). Wiley.https://doi.org/10.1111/j.1439-0507.2010.01884.x
  4. Garzoni, C., Nobre, V. A., & Garbino, J. (2007). Candida parapsilosis endocarditis: a comparative review of the literature. In European Journal of Clinical Microbiology & Infectious Diseases (Vol. 26, Issue 12, pp. 915–926). Springer Science and Business Media LLC.https://doi.org/10.1007/s10096-007-0386-1
  5. Rubinstein, E., & Lang, R. (1995). Fungal endocarditis. In European Heart Journal (Vol. 16, Issue suppl B, pp. 84–89). Oxford University Press (OUP).https://doi.org/10.1093/eurheartj/16.suppl_b.84
  6. Shin, J. H., Kee, S. J., Shin, M. G., Kim, S. H., Shin, D. H., Lee, S. K., Suh, S. P., & Ryang, D. W. (2002). Biofilm Production by Isolates of Candida Species Recovered from Nonneutropenic Patients: Comparison of Bloodstream Isolates with Isolates from Other Sources. In Journal of Clinical Microbiology (Vol. 40, Issue 4, pp. 1244–1248). American Society for Microbiology.https://doi.org/10.1128/jcm.40.4.1244-1248.2002
  7. Baddley, J.W., Benjamin, D.K., Patel, M. et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 27, 519–529 (2008).https://doi.org/10.1007/s10096-008-0466-x
  8. Pierrotti, L. C., & Baddour, L. M. (2002). Fungal endocarditis, 1995-2000. Chest, 122(1), 302–310.https://doi.org/10.1378/chest.122.1.302
  9. Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012). Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS microbiology reviews, 36(2), 288–305.https://doi.org/10.1111/j.1574-6976.2011.00278.x
  10. Fernández-Ruiz, M., Aguado, J. M., Almirante, B., Lora-Pablos, D., Padilla, B., Puig-Asensio, M., Montejo, M., García-Rodríguez, J., Pemán, J., Ruiz Pérez de Pipaón, M., Cuenca-Estrella, M., CANDIPOP Project, GEIH-GEMICOMED (SEIMC), & REIPI (2014). Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America , 58 (10), 1413–1421.https://doi.org/10.1093/cid/ciu158
  11. Lefort, A., Chartier, L., Sendid, B., Wolff, M., Mainardi, J. L., Podglajen, I., Desnos-Ollivier, M., Fontanet, A., Bretagne, S., Lortholary, O., & French Mycosis Study Group (2012). Diagnosis, management and outcome of Candida endocarditis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(4), E99–E109.https://doi.org/10.1111/j.1469-0691.2012.03764.x
  12. Pasha, A. K., Lee, J. Z., Low, S. W., Desai, H., Lee, K. S., & Al Mohajer, M. (2016). Fungal Endocarditis: Update on Diagnosis and Management. The American journal of medicine, 129(10), 1037–1043.https://doi.org/10.1016/j.amjmed.2016.05.012
  13. Trofa, D., Gácser, A., & Nosanchuk, J. D. (2008). Candida parapsilosis , an Emerging Fungal Pathogen. In Clinical Microbiology Reviews (Vol. 21, Issue 4, pp. 606–625). American Society for Microbiology.https://doi.org/10.1128/cmr.00013-08
  14. Tóth, R., Nosek, J., Mora-Montes, H. M., Gabaldon, T., Bliss, J. M., Nosanchuk, J. D., Turner, S. A., Butler, G., Vágvölgyi, C., & Gácser, A. (2019). Candida parapsilosis: from Genes to the Bedside. In Clinical Microbiology Reviews (Vol. 32, Issue 2). American Society for Microbiology.https://doi.org/10.1128/cmr.00111-18
  15. Kuhn, D. M., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002). Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infection and immunity, 70(2), 878–888.https://doi.org/10.1128/IAI.70.2.878-888.2002
  16. Rivoisy, C., Vena, A., Schaeffer, L., Charlier, C., Fontanet, A., Delahaye, F., Bouza, E., Lortholary, O., Munoz, P., Lefort, A., & French Mycoses Study Group and Grupo de Apoyo al Manejo de las Endocarditis en España (GAMES) (2018). Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(6), 825–832.https://doi.org/10.1093/cid/cix913
  17. Madakshira, M. G., Bal, A., ShivaPrakash, Rathi, M., & Vijayvergiya, R. (2018). Candida parapsilosis endocarditis in an intravenous drug abuser: an autopsy report. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology ,36 , 30–34.https://doi.org/10.1016/j.carpath.2018.05.005
  18. Jain, A. G., Guan, J., & D’Souza, J. (2018). Candida parapsilosis: An Unusual Cause of Infective Endocarditis. In Cureus. Cureus, Inc.https://doi.org/10.7759/cureus.3553
  19. Ellis, M. E., Al-Abdely, H., Sandridge, A., Greer, W., & Ventura, W. (2001). Fungal endocarditis: evidence in the world literature, 1965-1995. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 32(1), 50–62.https://doi.org/10.1086/317550
  20. Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., Zaoutis, T. E., & Sobel, J. D. (2015). Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. In Clinical Infectious Diseases (Vol. 62, Issue 4, pp. e1–e50). Oxford University Press (OUP).https://doi.org/10.1093/cid/civ933
  21. Ahuja, T., Fong, K., & Louie, E. (2019). Combination antifungal therapy for treatment of Candida parapsilosis prosthetic valve endocarditis and utility of T2Candida Panel®: A case series. In IDCases (Vol. 15, p. e00525). Elsevier BV.https://doi.org/10.1016/j.idcr.2019.e00525
  22. Muñoz, P., Vena, A., Valerio, M., Álvarez-Uría, A., Guinea, J., Escribano, P., & Bouza, E. (2016). Risk factors for late recurrent candidaemia. A retrospective matched case–control study. In Clinical Microbiology and Infection (Vol. 22, Issue 3, p. 277.e11-277.e20). Elsevier BV.https://doi.org/10.1016/j.cmi.2015.10.023
  23. Mamtani, S. S., Aljanabi, N. M., Gupta Rauniyar, R. P., Acharya, A., & Malik, B. H. (2020). Candida Endocarditis: A Review of the Pathogenesis, Morphology, Risk Factors, and Management of an Emerging and Serious Condition. In Cureus. Cureus, Inc.https://doi.org/10.7759/cureus.6695
  24. Tumbarello, M., Fiori, B., Trecarichi, E. M., Posteraro, P., Losito, A. R., De Luca, A., Sanguinetti, M., Fadda, G., Cauda, R., & Posteraro, B. (2012). Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital. PloS one, 7(3), e33705.https://doi.org/10.1371/journal.pone.0033705